MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)

MIR181Aregulates starvation- and rapamycin-induced autophagy through targeting ofATG5

(2013) Kumsal Ayse Tekirdag et al.   Autophagy

PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy

(2013) Seth A. Wander et al.   BREAST CANCER RESEARCH AND TREATMENT

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer

(2013) Andrea BISSO et al.   CELL CYCLE

miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2

(2012) H. Li et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells

(2012) Vicky Goler-Baron et al.   BIOCHEMICAL PHARMACOLOGY

Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast

(2012) Shuai Li et al.   BREAST CANCER RESEARCH AND TREATMENT

miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes

(2012) Dan-Xia Zhu et al.   CARCINOGENESIS

Cancer Regulator MicroRNA: Potential Relevance in Diagnosis, Prognosis and Treatment of Cancer

(2012) G. Fiorucci et al.   CURRENT MEDICINAL CHEMISTRY

TGF-β upregulates miR-181a expression to promote breast cancer metastasis

(2012) Molly A. Taylor et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-181a Post-Transcriptionally Downregulates Oncogenic RalA and Contributes to Growth Inhibition and Apoptosis in Chronic Myelogenous Leukemia (CML)

(2012) Jia Fei et al.   PLoS One

Sensitivity to TOP2 Targeting Chemotherapeutics Is Regulated by Oct1 and FILIP1L

(2012) Huarui Lu et al.   PLoS One

MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6

(2012) Xiangyang Zhang et al.   TUMOR BIOLOGY

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

(2011) Jin Hou et al.   CANCER CELL

Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells

(2011) J. Selever et al.   CLINICAL CANCER RESEARCH

miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis

(2011) Haitao Bai et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924

(2011) X. Hou et al.   MOLECULAR CANCER THERAPEUTICS

Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma

(2011) Junfang Ji et al.   Cell and Bioscience

Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression

(2011) Takeo Nakanishi et al.   Chinese Journal of Cancer

miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras

(2010) Ki-Hyuk Shin et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion and side populations

(2010) F Wang et al.   BRITISH JOURNAL OF CANCER

miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death

(2010) L. Galluzzi et al.   CANCER RESEARCH

Molecular biology of breast cancer stem cells: Potential clinical applications

(2010) Nam P. Nguyen et al.   CANCER TREATMENT REVIEWS

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

(2010) Zhanglin Ni et al.   CURRENT DRUG METABOLISM

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

(2010) Igor P. Pogribny et al.   INTERNATIONAL JOURNAL OF CANCER

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1

(2009) Zhongxing Liang et al.   BIOCHEMICAL PHARMACOLOGY

Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth

(2009) G. Maillot et al.   CANCER RESEARCH

miR-181a Regulates Cap-Dependent Translation of p27kip1 mRNA in Myeloid Cells

(2009) R. Cuesta et al.   MOLECULAR AND CELLULAR BIOLOGY

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2

(2009) K. K.W. To et al.   MOLECULAR CANCER THERAPEUTICS

MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells

(2009) Y.-Z. Pan et al.   MOLECULAR PHARMACOLOGY

A Novel Two Mode-Acting Inhibitor of ABCG2-Mediated Multidrug Transport and Resistance in Cancer Chemotherapy

(2009) Hui Peng et al.   PLoS One

Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line

(2008) K. K. W. To et al.   MOLECULAR AND CELLULAR BIOLOGY

The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice

(2008) Neri Mercatelli et al.   PLoS One